FN1 and lymphangioleiomyomatosis: The low levels we have observed in LAM serum may be due to the aggregation of vWF at the cystic regions in the lungs which was confirmed in immunohistochemical analysis of LAM lung tissue, much the same as fibronectin deposition observed in LAM patients.